Boston Partners’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Boston Partners’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-39,657	Closed	-$212K	–	844
2023 Q4	$212K	Sell	39,657 -31,535	-44%	-$194K	﹤0.01%	682
2023 Q3	$570K	Buy	71,192 +13,444	+23%	+$79.9K	﹤0.01%	622
2023 Q2	$245K	Hold	57,748	–	–	﹤0.01%	679
2023 Q1	$325K	Buy	57,748 +45,650	+377%	+$347K	﹤0.01%	642
2022 Q4	$100K	Buy	12,098 +5,202	+75%	+$102K	﹤0.01%	680
2022 Q3	$222K	Buy	+6,896	New	+$256K	﹤0.01%	674

Boston Partners's SNCE Position: Q1 2024 in Review

Boston Partners sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 39,657 shares — an estimated $212K sold.

Boston Partners first reported a position in SNCE in Q3 2022 and held it in 6 quarters. The position peaked at $570K in Q3 2023. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.

Boston Partners reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Boston Partners sold 39,657 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $212K.
Boston Partners first reported a position in Science 37 Holdings, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
Boston Partners's Science 37 Holdings, Inc. Common Stock position peaked at $570K in Q3 2023.
0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.

Based on Boston Partners's 13F filing for Q1 2024, filed 13 May 2024.